Royal Bank of Canada’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3K | Sell |
505
-136
| -21% | -$808 | ﹤0.01% | 6376 |
|
2025
Q1 | $2K | Buy |
641
+297
| +86% | +$927 | ﹤0.01% | 6214 |
|
2024
Q4 | $2K | Sell |
344
-2,235
| -87% | -$13K | ﹤0.01% | 6239 |
|
2024
Q3 | $37K | Buy |
2,579
+2,300
| +824% | +$33K | ﹤0.01% | 5380 |
|
2024
Q2 | $20K | Buy |
279
+31
| +13% | +$2.22K | ﹤0.01% | 5691 |
|
2024
Q1 | $15K | Sell |
248
-628
| -72% | -$38K | ﹤0.01% | 5598 |
|
2023
Q4 | $64K | Sell |
876
-78
| -8% | -$5.7K | ﹤0.01% | 5346 |
|
2023
Q3 | $37K | Sell |
954
-17
| -2% | -$659 | ﹤0.01% | 5447 |
|
2023
Q2 | $55K | Buy |
971
+547
| +129% | +$31K | ﹤0.01% | 5285 |
|
2023
Q1 | $27K | Buy |
424
+139
| +49% | +$8.85K | ﹤0.01% | 5532 |
|
2022
Q4 | $8K | Buy |
285
+1
| +0.4% | +$28 | ﹤0.01% | 6150 |
|
2022
Q3 | $8K | Sell |
284
-30,000
| -99% | -$845K | ﹤0.01% | 6064 |
|
2022
Q2 | $581K | Buy |
30,284
+29,964
| +9,364% | +$575K | ﹤0.01% | 3533 |
|
2022
Q1 | $26K | Sell |
320
-219
| -41% | -$17.8K | ﹤0.01% | 5986 |
|
2021
Q4 | $49K | Buy |
539
+267
| +98% | +$24.3K | ﹤0.01% | 5857 |
|
2021
Q3 | $35K | Buy |
272
+75
| +38% | +$9.65K | ﹤0.01% | 5850 |
|
2021
Q2 | $22K | Sell |
197
-11
| -5% | -$1.23K | ﹤0.01% | 6025 |
|
2021
Q1 | $31K | Buy |
208
+68
| +49% | +$10.1K | ﹤0.01% | 5688 |
|
2020
Q4 | $16K | Buy |
140
+32
| +30% | +$3.66K | ﹤0.01% | 5618 |
|
2020
Q3 | $8K | Sell |
108
-2
| -2% | -$148 | ﹤0.01% | 5522 |
|
2020
Q2 | $12K | Sell |
110
-37
| -25% | -$4.04K | ﹤0.01% | 5303 |
|
2020
Q1 | $16K | Sell |
147
-69
| -32% | -$7.51K | ﹤0.01% | 5144 |
|
2019
Q4 | $34K | Buy |
216
+109
| +102% | +$17.2K | ﹤0.01% | 5037 |
|
2019
Q3 | $16K | Hold |
107
| – | – | ﹤0.01% | 4994 |
|
2019
Q2 | $12K | Sell |
107
-5
| -4% | -$561 | ﹤0.01% | 5136 |
|
2019
Q1 | $12K | Buy |
112
+4
| +4% | +$429 | ﹤0.01% | 5063 |
|
2018
Q4 | $9K | Sell |
108
-21
| -16% | -$1.75K | ﹤0.01% | 5153 |
|
2018
Q3 | $21K | Buy |
129
+2
| +2% | +$326 | ﹤0.01% | 5053 |
|
2018
Q2 | $25K | Buy |
+127
| New | +$25K | ﹤0.01% | 4865 |
|